Showing results (1-10 of 217) with videos related to
Sort By:
Pageof 22
Oncogene|November 26, 2009
Rictor is a novel target of p70 S6 kinase-1C Treins, P H Warne, M A Magnuson, et al.Oncogene|March 2, 2011
PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugsB Weigelt, P H Warne, J DownwardOncogene|October 5, 1995
Downregulation of the Ras activation pathway by MAP kinase phosphorylation of SosL Buday, P H Warne, J DownwardOncogene|December 1, 1994
Role of Shc in the activation of Ras in response to epidermal growth factor and nerve growth factorT Basu, P H Warne, J DownwardNature|July 22, 1993
Direct interaction of Ras and the amino-terminal region of Raf-1 in vitroP H Warne, P R Viciana, J DownwardOncogene|June 20, 1996
Networks of interaction of p120cbl and p130cas with Crk and Grb2 adaptor proteinsA Khwaja, B Hallberg, P H Warne, et al.Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 29, 1996
Phosphatidylinositol 3' kinase: one of the effectors of RasP Rodriguez-Viciana, B M Marte, P H Warne, et al.The EMBO Journal|May 15, 1997
Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathwayA Khwaja, P Rodriguez-Viciana, S Wennström, et al.The EMBO Journal|May 15, 1996
Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutationP Rodriguez-Viciana, P H Warne, B Vanhaesebroeck, et al.Current Biology : CB|January 1, 1997
R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathwaysB M Marte, P Rodriguez-Viciana, S Wennström, et al.Pageof 22